Target intelligence / Profile preview

Lipocalin 1 pseudogene 1 (LCN1P1)

Target
LCN1P1
Molecular classification
Other (Pseudogene), non-functional (processed) pseudogene of the lipocalin family
01

Overview

Lipocalin 1 pseudogene 1 (LCN1P1) is a pseudogene related to the lipocalin gene family, located on human chromosome 9. It is not believed to code for a functional protein; pseudogenes are typically inactive genetic sequences that resemble functional genes but lack the ability to produce a protein product. Although LCN1P1 is predicted to have small molecule binding activity and is located in the extracellular space, there is no evidence it produces an expressed or biologically active protein in humans. No therapeutic, diagnostic, or disease associations have been established for LCN1P1[2].\n\nMolecular classification: LCN1P1 is not an enzyme, receptor, transporter, or transcription factor—its primary classification is as a non-functional (processed) pseudogene of the lipocalin family[2].\nBiological functions and disease roles: No biological function or disease association is reported or suspected, in contrast to the functional protein-coding LCN1 gene, which is involved in extracellular transport of small hydrophobic molecules in tears[2][3].\nPharmacology: No drugs, mechanisms of action, biomarkers, or safety concerns are associated with LCN1P1, as it does not encode an active protein[2].\n\nSummary: LCN1P1 is not a therapeutic target, but a genomic relic of the lipocalin family; only the related LCN1 gene encodes an active protein with physiological and clinical relevance[2][3].

Other names
Putative lipocalin 1-like protein 1LCN1L1bA430N14.2Lipocalin 1-like pseudogene 1lipocalin 1 (tear prealbumin) pseudogenelipocalin 1-like 1

Beyond the preview

Go deeper on Lipocalin 1 pseudogene 1 (LCN1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipocalin 1 pseudogene 1 (LCN1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call